Page last updated: 2024-08-16

terfenadine and fenfluramine

terfenadine has been researched along with fenfluramine in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Friedman, MA; Hass, AE; Lumpkin, MM; Shuren, JE; Thompson, LJ; Woodcock, J	1

Other Studies

2 other study(ies) available for terfenadine and fenfluramine

Article	Year
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
The safety of newly approved medicines: do recent market removals mean there is a problem? JAMA, 1999, May-12, Volume: 281, Issue:18 Topics: Adverse Drug Reaction Reporting Systems; Anti-Allergic Agents; Anti-Inflammatory Agents, Non-Steroidal; Appetite Depressants; Benzimidazoles; Benzophenones; Bromobenzenes; Calcium Channel Blockers; Dexfenfluramine; Drug and Narcotic Control; Drug Approval; Fenfluramine; Product Surveillance, Postmarketing; Terfenadine; Tetrahydronaphthalenes; United States; United States Food and Drug Administration	1999

Article

Year

Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.

Current drug discovery technologies, 2004, Volume: 1, Issue:4

Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004

The safety of newly approved medicines: do recent market removals mean there is a problem?

JAMA, 1999, May-12, Volume: 281, Issue:18

Topics: Adverse Drug Reaction Reporting Systems; Anti-Allergic Agents; Anti-Inflammatory Agents, Non-Steroidal; Appetite Depressants; Benzimidazoles; Benzophenones; Bromobenzenes; Calcium Channel Blockers; Dexfenfluramine; Drug and Narcotic Control; Drug Approval; Fenfluramine; Product Surveillance, Postmarketing; Terfenadine; Tetrahydronaphthalenes; United States; United States Food and Drug Administration

1999